尿路上皮

尿路上皮癌mdm-2、p53蛋白及性激素受体免疫组化研究

Expression of mdm-2 、 p53 Protein , AR and ER in Urothelium Carcinoma

尿路上皮癌p53bax基因蛋白的表达及意义

Study of Expression of bax and p53 proteins in Urothelium Carcinoma

膀胱尿路上皮癌的MR分期与病理对照

Staging of urothelial carcinoma with MR correlated with Pathology in bladder

VEGF与膀胱尿路上皮癌微血管密度及预后的相关性研究

Correlation of VEGF expression with MVD and prognosis in human bladder urothelium cancer

尿路上皮肿瘤rasp21和p53蛋白和DNA含量的流式细胞定量研究

Quantitative Study of ras p21 , p53 Protein Expression and DNA Content in Urothelial Tumors

COX-2与VEGF在膀胱尿路上皮癌中的表达及相互关系

The expressions and relationship of COX-2 and VEGF protein in bladder transitional cell carcinoma

膀胱尿路上皮癌MMP-2表达及其与FAK、p53、bcl-2、Ki-67的关系

Expression of MMP-2 in bladder urothelial carcinoma and its relationship with FAK , p53 , bcl-2 and Ki-67

凋亡基因ras突变和rasp21蛋白表达与尿路上皮肿瘤预后关系

Ras Gene Mutation and Ras P21 Protein Overexpression and DNA Abnormality in Urothelial Tumors Correlated with Its Prognosis

RNA干扰hTR基因对膀胱尿路上皮癌BIU-87细胞株端粒酶活性的影响

RNA interference of the hTR gene inhibits telomerase activity of bladder cancer BIU-87 cell line

目的研究ras、P53基因突变和蛋白表达以及DNA倍体异常与尿路上皮肿瘤预后的关系。

Objective To research for the relationship between ras , P53 gene mutation , protein expression , abnormal DNA ploidy and the prognosis of urothelioma .

外界因素直接或者间接作用，可以诱发膀胱尿路上皮细胞DNA异常改变，从而引起细胞生长失控，最终激活膀胱癌发生的共同生物学通路。

Direct or indirect effects of external factors , can induce DNA abnormalities of urothelial cell , which led to the final common biological pathway of uncontrolled cell growth of bladder cancer .

膀胱尿路上皮癌组织中Ezrin和E-cadherin的表达

Expressions of Ezrin and E-cadherin in bladder urothelial carcinoma and their correlation with metastasis

目的探讨Toll样受体（Toll-likereceptor，TLR）2和4在人尿路上皮细胞中的表达情况。

Objective To study the mRNA expression of Toll-like receptor ( TLR ) 2 and 4 in human urinary tract epithelium .

GC方案治疗晚期尿路上皮癌近期疗效评价三维适形放射治疗技术治疗复发性宫颈癌的短期疗效评估

Study of short-term efficacy of gemcitabine plus cisplatin in treating advanced urothelial carcinoma Curative effect of 3-dimensional conformal radiotherapy for recurrence cervix cancer : report of 42 cases

NMP22肿瘤标志物诊断尿路上皮癌的初步评价

Evaluation of NMP22 in Detection of Urinary Tract Transitional Cell Carcinoma

Wnt通路抑制因子Wif-1在膀胱尿路上皮细胞癌中的表达和意义

The Expression and Significance of Wnt Inhibitory Factor-1 in Bladder Urothelial Cell Carcinoma

结论1、Snail蛋白高表达及E-cadherin蛋白低表达与膀胱尿路上皮癌的浸润和转移密切相关。

The high expression of Snail and low expression of E-cadherin in bladder urothelial carcinoma are involved in the processes of invasion and metastasis of bladder urothelial carcinoma .

方法：对48例尿路上皮肿瘤患者，在行膀胱镜检查或手术前留新鲜尿液分别行尿脱落细胞survivin、尿nmp22和尿脱落细胞检查，并分别比较各方法的敏感性、特异性。

Methods : Patients of transitional cell carcinoma were asked to have survivin in urinary exfoliative cell , urine nmp22 and cytological examination before cystoscopy or operation .

结论人尿路上皮细胞中TLR2和TLR4均有表达，尿路感染致病菌分布量可能与TLR亚型表达情况有关。

Conclusion That TLR2 and TLR4 both expressed in human urinary tract epithelium is probably associated with the distribution of uropathogenic bacteria .

目的：探讨KAI1基因的表达与尿路上皮癌的发生及浸润转移的关系。

Objective : To investigate the expression of KAI1 gene in the urothelial cancer tissues and its relationship with the invasion and metastasis of urothelial cancer .

目的：探讨粘蛋白（MUC1）和MUC2蛋白在膀胱尿路上皮细胞癌中的表达及其与临床病理的相关性。

Objective : To investigate the expression of MUC1 and MUC2 proteins and their significance in human bladder transitional cell carcinoma ( BTCC ) .

[目的]探讨体外诱导骨髓间充质干细胞（BMSCs）向膀胱平滑肌细胞和尿路上皮细胞分化的方法，为组织工程膀胱的建立提供一种新的种子细胞来源。

Objectives To explore the method of inducing BMSCs differentiate to urothelial epithelia and smooth muscle cells ( SMCs ) in vitro , and to look for a new source of seed cells for the construction of tissue engineering bladder .

本研究旨在分析中国人膀胱尿路上皮癌中染色体畸变的情况，探讨多色荧光原位杂交（multicolorfluorescenceinsituhybridization，M-FISH）技术辅助诊断膀胱尿路上皮癌的可行性和有效性。

This study was to analyze chromosome aberrations in urothelial carcinoma of the urinary bladder in Chinese , and evaluate the possibility and validity of multicolor fluorescence in situ hybridization ( M-FISH ) in detecting urothelial carcinoma of the urinary bladder .

方法：应用免疫酶标记法（ELISA）检测58例尿路上皮癌、32例良性泌尿系疾病、18例其他恶性肿瘤和20例健康志愿者尿中NMP22水平。

Methods : Urinary NMP22 values were determined for 58 patients with urothelial transitional cell carcinomas ( TCC ), 32 with benign urological diseases , 18 with other cancers and 20 healthy volunteers by an enzyme-linked immunosorbent assay ( ELISA );

方法：①选择兔膀胱尿路上皮细胞、兔膀胱平滑肌细胞及兔骨髓间充质干细胞（BMSC）作为种子细胞，采用相应的培养及纯化策略，获取满足实验要求的种子细胞。

Methods : ( 1 ) Bladder urothelium , bladder smooth muscle cells and bone marrow mesenchymal stem cells ( BMSC ) were choose as seed cells , primary culture and purify system were build to proliferate the seed cells .

目的研究原肌球蛋白5（TM5）在膀胱尿路上皮癌（BUC）中的表达，探讨TM5与膀胱癌生物学行为之间的关系。

Objective To investigate the expressions and clinical significance of the tropomyosin-5 ( TM5 ) in the bladder urothelial carcinoma ( BUC ) to probe into its correlation with tumor .

结果尿路上皮肿瘤、非尿路上皮性肿瘤和泌尿男生殖系统良性病变者尿NMP22阳性率分别为88.7%（165/186）、37.2%（32/86）和29.8%（14/47）。

Results The positive rate of NMP 22 of urine was 88.7 % ( 165 / 186 ) in urothelial tumors , 37.2 % ( 32 / 86 ) in non-urothelial tumors and 29.8 % ( 14 / 47 ) in benign genitourinary diseases , respectively .

目的：结合文献复习探讨膀胱低度恶性潜能乳头状尿路上皮肿瘤（PUNLMP）临床病理学、免疫组化、鉴别诊断及预后。

Objective : To explore the clinicopathological and immunohistochemical features , differential diagnosis , and prognosis of papillary urothelial neoplasm of low malignant potential ( PUNLMP ), and to review the literature .

目的探讨上尿路上皮癌合适的诊断方法。

Objective To study the suitable diagnostic methods for urothelial cancers .

异时性尿路上皮移行细胞癌（附10例报告）

Clinical features of metachronous urothelial TCC ( report of 10 cases )